Taken together, these results suggest that the FLRT3/LPHN/Tim-3/galectin-9 pathway possibly functions mainly to transfer galectin-9 onto the cell surface rather than to secrete it as in the case with AML cells. This evidence concerns the gene HAVCR2 and acute myeloid leukemia.